Maurizio Bonati is professor of public health at the Istituto di Ricerche Farmacologiche Mario Negri IRCSS in Milan, Italy.
Maurizio Bonati
Professor
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
From this contributor
Clinicians should consider off-label treatments for autism
Clinicians need a more consistent and evidence-based approach to prescribing antipsychotics to children and adolescents with autism.
Clinicians should consider off-label treatments for autism
By
Maurizio Bonati
7 May 2019 | 5 min read
Explore more from The Transmitter
Acetaminophen effects on developing brain organoids; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 12 October.
Acetaminophen effects on developing brain organoids; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 12 October.
By
Jill Adams
13 October 2026 | 1 min read
Private initiative makes ‘historic’ investment in autism research
Aligning Research to Impact Autism has committed more than $450 million to build a new multidisciplinary research network to uncover the roots of profound autism and develop treatments.
Private initiative makes ‘historic’ investment in autism research
Aligning Research to Impact Autism has committed more than $450 million to build a new multidisciplinary research network to uncover the roots of profound autism and develop treatments.
By
Madeline Shaw
13 October 2026 | 4 min read
The neural code at 100
In two 1926 articles, Edgar Douglas Adrian revealed that neurons communicate through trains of spikes.
The neural code at 100
In two 1926 articles, Edgar Douglas Adrian revealed that neurons communicate through trains of spikes.
By
Matteo Carandini
12 October 2026 | 8 min read